VIV vs MEDP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
VIV · Telefonica Brasil$11.43 ▲ 0.97%
MEDP · Medpace$653.11 ▲ 2.86%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- VIV -2.8%
- MEDP +8.8%
Head to head
| Metric | VIV | MEDP |
|---|---|---|
| Price | $11.43 | $653.11 |
| Change today | ▲ 0.97% | ▲ 2.86% |
| Market cap | $18.26B | $18.27B |
| Return, 3 months | -3.3% | +8.4% |
| Return, year to date | +2.5% | +16.3% |
| Return, 1 year | -2.4% | +10.9% |
| P/E (TTM) | 15.3 | 36.3 |
| P/B | 1.5 | 31.2 |
| P/E percentile vs own 5y | 35th | 75th |
| Dividend yield | 8.42% | – |
| Revenue growth (YoY, latest qtr) | +7.6% | +8.5% |
| Net profit growth (YoY) | +17.1% | +23.7% |
| Gross margin | 45.0% | 29.1% |
| Operating margin | 17.1% | 21.4% |
| Net margin | 10.7% | 18.2% |
| Return on equity | 9.9% | 117.9% |
| Analyst target vs. price | +22.5% | +5.8% |
| Analyst buy share | 0% | 38% |
| RSI (14) | 43 | 53 |
| 30-day volatility | 52.0% | 36.6% |
| Max drawdown, 1 year | -32.1% | -36.6% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MEDP is the largest of the group by market value.
- MEDP has returned the most over the past year.
- VIV carries the lowest trailing P/E.
- MEDP is growing revenue fastest.
- MEDP keeps the most profit per dollar of sales.
- MEDP has been the calmest stock over the last 30 days.